BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10228452)

  • 1. Cycloalkyl indole-2-carboxylates as useful tools for mapping the "north-eastern" region of the glycine binding site associated with the NMDA receptor.
    Micheli F; Di Fabio R; Capelli AM; Cugola A; Curcuruto O; Feriani A; Gastaldi P; Gaviraghi G; Marchioro C; Orlandi A; Pozzan A; Quaglia AM; Reggiani A; van Amsterdam F
    Arch Pharm (Weinheim); 1999 Mar; 332(3):73-80. PubMed ID: 10228452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.
    Di Fabio R; Capelli AM; Conti N; Cugola A; Donati D; Feriani A; Gastaldi P; Gaviraghi G; Hewkin CT; Micheli F; Missio A; Mugnaini M; Pecunioso A; Quaglia AM; Ratti E; Rossi L; Tedesco G; Trist DG; Reggiani A
    J Med Chem; 1997 Mar; 40(6):841-50. PubMed ID: 9083472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted analogues of GV150526 as potent glycine binding site antagonists in animal models of cerebral ischemia.
    Di Fabio R; Conti N; De Magistris E; Feriani A; Provera S; Sabbatini FM; Reggiani A; Rovatti L; Barnaby RJ
    J Med Chem; 1999 Sep; 42(18):3486-93. PubMed ID: 10479281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists.
    Balsamini C; Bedini A; Diamantini G; Spadoni G; Tontini A; Tarzia G; Di Fabio R; Feriani A; Reggiani A; Tedesco G; Valigi R
    J Med Chem; 1998 Mar; 41(6):808-20. PubMed ID: 9526557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]5,7-dichlorokynurenic acid recognizes two binding sites in rat cerebral cortex membranes.
    Mugnaini M; Antolini M; Corsi M; van Amsterdam FT
    J Recept Signal Transduct Res; 1998; 18(2-3):91-112. PubMed ID: 9651880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.
    Baron BM; Harrison BL; Kehne JH; Schmidt CJ; van Giersbergen PL; White HS; Siegel BW; Senyah Y; McCloskey TC; Fadayel GM; Taylor VL; Murawsky MK; Nyce P; Salituro FG
    Eur J Pharmacol; 1997 Apr; 323(2-3):181-92. PubMed ID: 9128837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
    Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
    Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
    Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel indole-2-carboxylates as ligands for the strychnine-insensitive N-methyl-D-aspartate-linked glycine receptor.
    Gray NM; Dappen MS; Cheng BK; Cordi AA; Biesterfeldt JP; Hood WF; Monahan JB
    J Med Chem; 1991 Apr; 34(4):1283-92. PubMed ID: 1849994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.
    Jansen M; Potschka H; Brandt C; Löscher W; Dannhardt G
    J Med Chem; 2003 Jan; 46(1):64-73. PubMed ID: 12502360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant activity of antagonists for the NMDA-associated glycine binding site.
    Nichols AC; Yielding KL
    Mol Chem Neuropathol; 1993 Aug; 19(3):269-82. PubMed ID: 8397587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
    J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycine derivatives of imidazolones as potential ligands of glycine binding site of NMDA receptors. Part 1.
    Kieć-Kononowicz K; Karolak-Wojciechowska J; Handzlik J
    Acta Pol Pharm; 1998; 55(5):381-8. PubMed ID: 9921116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles.
    Kehne JH; Baron BM; Harrison BL; McCloskey TC; Palfreyman MG; Poirot M; Salituro FG; Siegel BW; Slone AL; Van Giersbergen PL
    Eur J Pharmacol; 1995 Sep; 284(1-2):109-18. PubMed ID: 8549613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
    Baron BM; Harrison BL; McDonald IA; Meldrum BS; Palfreyman MG; Salituro FG; Siegel BW; Slone AL; Turner JP; White HS
    J Pharmacol Exp Ther; 1992 Sep; 262(3):947-56. PubMed ID: 1388205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GV 150526A, 7-Cl-kynurenic acid and HA 966 antagonize the glycine enhancement of N-methyl-D-aspartate-induced [3H]noradrenaline and [3H]dopamine release.
    Mennini T; Mancini L; Reggiani A; Trist D
    Eur J Pharmacol; 1997 Oct; 336(2-3):275-81. PubMed ID: 9384243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.